Wellbutrin is primarily prescribed for major depressive disorder and seasonal affective disorder, but it’s also widely used off-label for smoking cessation, ADHD, and weight management. Its unique mechanism sets it apart from most antidepressants: rather than targeting serotonin, it works on dopamine and norepinephrine, two brain chemicals involved in motivation, focus, and energy. That distinction gives it a different side effect profile and makes it useful for a surprisingly broad range of conditions.
Depression and Seasonal Affective Disorder
The FDA has approved Wellbutrin XL for two conditions: major depressive disorder (MDD) and the prevention of seasonal depressive episodes in people diagnosed with seasonal affective disorder (SAD). For depression, the typical starting dose is 150 mg once daily, which can be increased to 300 mg. For SAD, doctors often start the medication in the fall before symptoms typically begin and taper it off in early spring.
Physical symptoms like disrupted sleep, low energy, and appetite changes tend to improve within one to two weeks. But the core emotional symptoms of depression, such as persistent sadness and loss of interest in things you used to enjoy, usually take six to eight weeks to fully respond. That lag can be frustrating, but it’s normal. Most clinicians recommend giving the medication a full trial of at least six weeks before concluding it isn’t working.
How It Differs From SSRIs
Most commonly prescribed antidepressants, including fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro), work by boosting serotonin levels. Wellbutrin takes a completely different approach, acting on dopamine and norepinephrine instead. This matters for two practical reasons that frequently drive prescribing decisions.
First, sexual side effects. SSRIs are well known for reducing sex drive, making it harder to become aroused, or delaying orgasm. Wellbutrin has one of the lowest rates of sexual side effects among all antidepressants. It’s so reliably better in this regard that doctors sometimes add it to an existing SSRI specifically to counteract sexual dysfunction caused by the other medication.
Second, weight. Many serotonin-based antidepressants are associated with gradual weight gain. Wellbutrin tends to be weight-neutral or even cause modest weight loss, which makes it a preferred choice for people concerned about that side effect.
Smoking Cessation
Bupropion (the generic name for Wellbutrin) is marketed under the brand name Zyban specifically for quitting smoking. Randomized controlled trials have consistently shown that it roughly doubles quit rates compared to placebo. A meta-analysis estimated that people taking bupropion were about 2.5 times more likely to stay smoke-free than those on a sugar pill.
The medication reduces cravings and withdrawal symptoms by acting on the same dopamine pathways that nicotine stimulates. For smoking cessation, the sustained-release formulation is typically started at 150 mg once daily for three days, then increased to 150 mg twice daily. Treatment usually begins one to two weeks before the planned quit date to let the medication build up in your system.
ADHD
Wellbutrin is not FDA-approved for attention deficit hyperactivity disorder, but it’s one of the most commonly prescribed off-label options, particularly for adults. Multiple studies with strong evidence levels have found it superior to placebo for ADHD symptoms. It’s considered an effective outpatient treatment option, especially for people who can’t tolerate stimulant medications or who have a history of substance use that makes stimulants a poor fit.
Because it boosts dopamine and norepinephrine (the same neurotransmitters targeted by stimulant ADHD medications like Adderall and Ritalin, though through a different mechanism), the overlap in brain chemistry makes sense. The effects on focus and attention are generally milder than what stimulants provide, but for many people the trade-off is worth it given the lower abuse potential and the bonus of treating co-occurring depression at the same time.
Weight Management
On its own, Wellbutrin produces modest but real weight loss. A 2024 meta-analysis covering over 12,000 participants across 25 randomized trials found that bupropion led to an average weight loss of about 8 pounds (3.7 kg) more than placebo. In routine clinical settings, patients typically achieve around 5% body weight loss at six months.
The FDA has also approved a combination of bupropion and naltrexone (sold as Contrave) specifically for chronic weight management. In large clinical trials of the combination, 48% of participants lost at least 5% of their body weight, compared to 17% on placebo. Patients on the combination averaged about 6% total body weight reduction over 56 weeks. That puts bupropion-based weight loss in the range of 4 to 6%, which is more modest than newer injectable medications but meaningful enough to improve metabolic health markers.
Three Formulations, Different Schedules
Wellbutrin comes in three forms, and the differences are practical rather than chemical. All contain the same active ingredient. The distinction is how quickly the pill releases it.
- Immediate-release (IR): Taken two to three times daily, at least six hours apart. This is the original formulation and the least convenient.
- Sustained-release (SR): Taken twice daily, at least eight hours apart. This is the version most commonly used for smoking cessation.
- Extended-release (XL): Taken once daily in the morning. This is the most commonly prescribed formulation for depression and SAD because of its simplicity.
The maximum daily dose across all formulations is generally 450 mg, though most people are treated at 300 mg or less. Taking it in the morning is standard because bupropion can be mildly stimulating and may interfere with sleep if taken later in the day.
Who Should Not Take It
Wellbutrin lowers the seizure threshold, which means it makes seizures slightly more likely. At standard doses up to 300 mg per day, the seizure rate is about 0.1%, or 1 in 1,000 patients. At higher doses (300 to 450 mg), that rises to roughly 0.4%. The risk is low in absolute terms, but it drives several important restrictions.
Wellbutrin is contraindicated for people with seizure disorders and for anyone with a current or past diagnosis of anorexia or bulimia, because eating disorders significantly increase seizure risk on this medication. It’s also not safe for anyone going through abrupt withdrawal from alcohol, benzodiazepines, or barbiturates, since withdrawal itself lowers the seizure threshold. And it cannot be combined with a class of older antidepressants called MAOIs; there must be at least a 14-day gap between the two.
Beyond seizures, the most common side effects are dry mouth, insomnia, nausea, and headache. Some people experience increased anxiety or restlessness, particularly in the first week or two. These effects often settle down as the body adjusts, but they’re worth knowing about upfront so you’re not caught off guard.